GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sonic Healthcare Ltd (ASX:SHL) » Definitions » 3-Year EPS without NRI Growth Rate

Sonic Healthcare (ASX:SHL) 3-Year EPS without NRI Growth Rate : 9.40% (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Sonic Healthcare 3-Year EPS without NRI Growth Rate?

Sonic Healthcare's EPS without NRI for the six months ended in Dec. 2023 was A$0.43.

During the past 12 months, Sonic Healthcare's average EPS without NRI Growth Rate was -49.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 9.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Sonic Healthcare was 61.70% per year. The lowest was 0.90% per year. And the median was 9.35% per year.


Competitive Comparison of Sonic Healthcare's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Sonic Healthcare's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonic Healthcare's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sonic Healthcare's 3-Year EPS without NRI Growth Rate falls into.



Sonic Healthcare 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Sonic Healthcare  (ASX:SHL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Sonic Healthcare 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sonic Healthcare's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonic Healthcare (ASX:SHL) Business Description

Traded in Other Exchanges
Address
225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.

Sonic Healthcare (ASX:SHL) Headlines

No Headlines